Le Lézard
Classified in: Health, Science and technology, Business
Subject: FNC

Physician-researcher awarded federal grant to bridge evidence and practice for clinicians via electronic medical record


MANHASSET, N.Y., April 10, 2019 /PRNewswire/ -- The US Department of Health & Human Services Agency for Healthcare Research and Quality (AHRQ) has awarded Thomas G. McGinn, MD, MPH, with a three-year, $1.14 million grant for a clinical decision support (CDS) system that reduces frontline providers' complications and frustrations. While clinical decision support has been widely available for years, healthcare providers have not adopted it widely because the systems are unwieldy and time-consuming for practitioners who are trying to access personalized clinical information and guidance in the real-time setting of patient encounters.

Thomas G. McGinn, MD, MPH, Feinstein Institute for Medical Research professor and Northwell Health senior vice president and deputy physician-in-chief.

For more than a decade, Dr. McGinn, Feinstein Institute for Medical Research professor and Northwell Health senior vice president and deputy physician-in-chief, and his team at the Feinstein Institute's Center for Health Innovations and Outcomes Research (CHIOR) have been studying, testing, and disseminating CDS in electronic health records. They focus on clinical prediction rules (CPRs), a form of CDS that uses a variety of data, mechanisms, and patient-specific information to calculate patient-specific probabilities. CPRs increase diagnostic accuracy, reduce unnecessary testing and treatment, and enhance quality and safety. To date, however, critical variations in electronic health record systems between and even within institutions have severely limited dissemination of CDS and its adoption into provider workflow.

The CDS system under development by CHIOR builds on widely validated CPRs for detecting blood clots in the lungs and for bleeding risk in hospitalized patients. The system's ability to impact care in emergency medicine and inpatient medical care settings will be assessed.

"When available at the point of care, clinical decision support allows physicians to blend medical acumen and evidence in real time," said Dr. McGinn, who also oversees Northwell's medicine programs and service line. "With AHRQ's support, we can design a system that targets and triggers the appropriate clinical prediction rules for the right people, at the right moment, incorporating patient-specific information and bringing evidence-based medicine directly to the point of care."

In December 2018, Safiya Richardson, MD, MPH, an assistant professor at the Zucker School of Medicine at Hofstra/Northwell and junior faculty researcher at the Feinstein Institute mentored by Dr. McGinn at CHIOR, was awarded a five-year grant from the National Institutes of Health to support her work in creating tools that help doctors make evidence-based clinical decisions. In the project's initial phase, Dr. Richardson will develop tool prototypes and test these with doctors.

"Evidence based medicine is the best medicine," said Kevin J. Tracey, MD, president and CEO of the Feinstein Institute. "Dr. McGinn's work advances this field by using the vast clinical information technology here at Northwell."

Dr. McGinn will be working closely with his co-investigators, including Sundas Khan, MD, administrative manager for research, and Jeffrey Solomon, Northwell's director of project clinical information systems. Northwell's key internal collaborators will include Michael Oppenheim, MD, VP and chief medical information officer, and John Chelico, MD, chief research information officer.

This project is funded under grant number R18 HS 026196 from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services.

About the Feinstein Institute for Medical Research
The research arm of Northwell Health, the Feinstein Institute is home to 50 research laboratories and to clinical research throughout dozens of hospitals and outpatient facilities. Its 4,000 researchers and staff are making breakthroughs in molecular medicine, genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine ? a new field of science that has the potential to revolutionize medicine. For more information about how we empower imagination and pioneer discovery, visit FeinsteinInstitute.org.

About Northwell Health
Northwell Health is New York State's largest healthcare provider and private employer, with 23 hospitals, nearly 700 outpatient facilities, and almost 15,000 affiliated physicians. We care for over two million people annually in the New York metro area and beyond, thanks to philanthropic support from our communities. Our 68,000 employees include more than 16,000 nurses and 4,000 employed doctors. In addition to making breakthroughs in medicine at the Feinstein Institute for Medical Research, we're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Graduate Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu.

Contact:   

David Robbins


516-465-8325


[email protected]

 

(PRNewsfoto/Northwell Health) (PRNewsfoto/Northwell Health)

SOURCE The Feinstein Institute for Medical Research


These press releases may also interest you

at 10:45
The "PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. 2023 to 2027" report has been added to...

at 10:31
Gulfstream Aerospace Corp., a wholly owned subsidiary of General Dynamics , today announced the all-new Gulfstream G700 has received Federal Aviation Administration (FAA) type certification, paving the way for customer deliveries of the most spacious...

at 10:30
The "Licensing Deals in Biotechnology 2019-2024" report has been added to ResearchAndMarkets.com's offering. Licensing Deals in Biotechnology provides a detailed understanding and analysis of how and why companies enter licensing deals. Fully...

at 10:30
The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering. Exciting technical...

at 10:30
RIVANNA®, a developer of imaging-based medical solutions, names Craig Loomis as senior director of product management. With over 25 years of extensive experience in global product development and commercialization within the healthcare sector, Mr....

at 10:15
The Micro-electro-mechanical System (MEMS) market is projected to grow from USD 16.5 billion in 2024 and is estimated to reach USD 24.2 billion by 2029; it is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.9% from 2024 to 2029...



News published on and distributed by: